CVE-2022-38765

CVE-2022-38765 is a medium-severity vulnerability in Canon Vitrea View with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-639.

Key facts

Description

Canon Medical Informatics Vitrea Vision 7.7.76.1 does not adequately enforce access controls. An authenticated user is able to gain unauthorized access to imaging records by tampering with the vitrea-view/studies/search patientId parameter.

Frequently asked questions

What is CVE-2022-38765?
Canon Medical Informatics Vitrea Vision 7.7.76.1 does not adequately enforce access controls. An authenticated user is able to gain unauthorized access to imaging records by tampering with the vitrea-view/studies/search patientId parameter.
How severe is CVE-2022-38765?
CVE-2022-38765 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2022-38765 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-38765?
CVE-2022-38765 affects Canon Vitrea View. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-38765?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2022-38765 published?
CVE-2022-38765 was published on 2022-12-09 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities

Browse all CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities →